RYM

+ Watchlist + Portfolio

RYTHM, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $20.75
52-Week Range: $14.00 – $53.65
Market Cap: $45.39M
P/E (TTM): —
EPS (TTM): -10.77
Dividend Yield: —

Advanced Metrics

Price/Book: 1.18
PEG Ratio: —
Return on Equity: -10.51%
Return on Assets: -8.90%
Gross Margin: 75.18%
Operating Margin: 8.41%
Profit Margin: -6.21%
Current Ratio: 0.59
Debt/Equity: 2.06
Total Debt: $80.62M
Free Cash Flow: $359.63K
Revenue Growth: 1027.40%
Earnings Growth: —
Enterprise Value: $84.73M

RYM Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$58.26M	$15.14M	$18.00K	$17.28M
Cost of Revenue	$90.05M	$11.12M	$89.00K	$7.09M
Gross Profit	-$31.80M	$4.02M	-$71.00K	$10.19M
Research & Development	$8.18M	$2.29M	$743.00K	—
Selling, General & Admin	$82.69M	$16.06M	$7.18M	$34.05M
Operating Expenses	$90.87M	$18.35M	$7.18M	$34.05M
Operating Income	-$122.67M	-$14.33M	-$7.25M	-$23.86M
EBITDA	-$119.62M	-$9.39M	-$21.55M	-$25.38M
Pretax Income	-$188.28M	-$13.43M	-$23.23M	-$34.74M
Income Tax	$23.00K	$2.00K	-$2.00K	$0.00
Net Income	-$188.17M	-$18.65M	-$41.75M	-$33.26M
Diluted EPS	-13532.85	-187.64	-40.92	-16.68
Diluted Shares	13904	99391	1.02M	1.99M

RYM Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$10.46M	$434.00K	$31.17M	$32.22M
Receivables	$1.49M	$1.20M	$200.00K	$9.32M
Inventory	$5.89M	$4.98M	$500.00K	$4.04M
Current Assets	$44.89M	$24.01M	$34.69M	$47.55M
Total Assets	$69.69M	$45.27M	$54.02M	$106.68M
Current Liabilities	$70.60M	$41.25M	$24.68M	$42.96M
Long-Term Debt	$407.00K	$16.05M	$1.00K	$50.00M
Total Debt	$31.71M	$21.80M	$10.52M	$80.62M
Total Liabilities	$78.73M	$59.98M	$25.93M	$93.66M
Retained Earnings	-$247.15M	-$265.80M	-$307.31M	-$340.80M
Shareholders' Equity	-$9.27M	-$14.94M	$28.09M	$13.02M
Working Capital	-$25.71M	-$17.24M	$10.02M	$4.59M
Net Debt	$18.78M	$20.82M	—	$48.40M

RYM Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$72.02M	-$30.98M	-$11.58M	-$23.54M
Capital Expenditure	-$8.13M	-$59.00K	-$4.00K	—
Free Cash Flow	-$80.16M	-$31.03M	-$11.59M	-$23.54M
Depreciation & Amortisation	$3.05M	$1.90M	$1.42M	$6.16M
Stock-Based Compensation	$4.32M	$2.66M	$1.17M	$2.16M
Investing Cash Flow	-$2.32M	$25.18M	-$54.00K	-$55.08M
Financing Cash Flow	$72.78M	-$4.23M	$42.37M	$79.66M
Net Change in Cash	-$1.56M	-$10.02M	$30.74M	$1.05M

RYM Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$538.00K	$2.04M	$4.04M	$10.66M	$13.29M
Cost of Revenue	$448.00K	$1.36M	$2.67M	$2.62M	$2.89M
Gross Profit	$90.00K	$682.00K	$1.38M	$8.04M	$10.40M
Research & Development	$0.00	$0.00	—	—	—
Selling, General & Admin	$3.79M	$7.48M	$10.26M	$12.52M	$14.43M
Operating Expenses	$3.79M	$7.48M	$10.26M	$12.52M	$14.43M
Operating Income	-$3.70M	-$6.80M	-$8.89M	-$4.48M	-$4.03M
EBITDA	-$3.37M	-$6.43M	-$7.79M	-$8.22M	-$591.00K
Pretax Income	-$3.27M	-$7.21M	-$10.63M	-$13.63M	-$5.67M
Income Tax	$0.00	$0.00	$0.00	$0.00	-$25.59M
Net Income	-$1.63M	-$7.36M	-$10.66M	-$13.61M	$19.92M
Diluted EPS	-0.83	-3.74	-5.33	-6.62	1.33
Diluted Shares	1.95M	1.97M	2.00M	2.05M	5.25M

RYM Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$24.45M	$40.96M	$35.57M	$32.22M	$33.26M
Receivables	$452.00K	$1.85M	$2.58M	$9.32M	$8.36M
Inventory	$738.00K	$2.21M	$4.62M	$4.04M	$3.06M
Current Assets	$27.18M	$46.37M	$43.89M	$47.55M	$46.26M
Total Assets	$45.62M	$69.47M	$115.15M	$106.68M	$127.52M
Current Liabilities	$18.21M	$17.54M	$22.06M	$42.96M	$90.36M
Long-Term Debt	—	$30.00M	$8.00M	$50.00M	—
Total Debt	$10.62M	$40.62M	$18.62M	$80.62M	$80.62M
Total Liabilities	$18.80M	$48.51M	$103.43M	$93.66M	$90.95M
Retained Earnings	-$309.17M	-$316.53M	-$327.19M	-$340.80M	-$320.88M
Shareholders' Equity	$26.82M	$20.96M	$11.72M	$13.02M	$36.58M
Working Capital	$8.96M	$28.83M	$21.83M	$4.59M	-$44.10M
Net Debt	—	—	—	$48.40M	$47.36M

RYM Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$6.72M	-$8.42M	-$5.38M	-$3.02M	$1.04M
Free Cash Flow	-$6.72M	-$8.42M	-$5.38M	-$3.02M	$1.04M
Depreciation & Amortisation	$336.00K	$484.00K	$1.71M	$3.63M	$3.44M
Stock-Based Compensation	$589.00K	$515.00K	$508.00K	$545.00K	$570.00K
Investing Cash Flow	$0.00	-$5.08M	-$50.00M	$0.00	—
Financing Cash Flow	-$1.00K	$30.00M	$50.00M	-$337.00K	$0.00
Net Change in Cash	-$6.72M	$16.51M	-$5.38M	-$3.35M	$1.04M

Market Snapshot

About

RYTHM, Inc. is a healthcare technology company developing digital therapeutics and neurotechnology solutions. The company focuses on non-invasive treatments for neurological conditions and sleep disorders. RYTHM combines hardware devices with software platforms to deliver personalized therapeutic interventions.